Exclusion criteria included: An intra-articular injection of any substance administered within the last 3 months, joint inflammatory diseases, microcrystalline arthropathies, current pregnancy ...

that reported on the occurrence of adverse events after intervention with local non-intra-articular corticosteroid injections were included. Studies concerning epidural injection and ...

Karl-Anthony Towns has a bone chip in his sprained right thumb, Stefan Bondy of The New York Post reports. The injury came on Monday, when Towns' New York Knicks lost to the Detroit Pistons.

Matt Kuhnemann is in serious doubt for the two-Test tour of Sri Lanka after the recalled spinner hurt his thumb playing for Brisbane Heat. The left-arm offspinner ran from the ground in agony on ...

Intra-Cellular Therapies ITCI signed a definitive agreement with pharma bigwig Johnson & Johnson JNJ. Per the terms, the pharma giant will acquire all outstanding shares of ITCI for $132 per share ...

Injections of a common household disinfectant could help make radiotherapy more effective against some types of breast cancer. Hydrogen peroxide creates a toxic environment for cancer cells.

Johnson & Johnson will acquire Intra-Cellular for $132 per share in cash, a 39 percent premium over Intra-Cellular's Friday closing price of $94.87. Following the announcement, shares of both ...

(AP Photo/Ted Shaffrey, File) Updated [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year] Johnson & Johnson will spend more than $14 billion to delve further into the treatment of central ...

Johnson & Johnson will acquire Intra-Cellular Therapies for $132 per share in a deal that values the company at $14.6 billion. The acquisition includes FDA-approved CAPLYTA for schizophrenia and ...

Mario Tama / Getty Images Shares of Intra-Cellular Therapies jumped Monday morning after Johnson & Johnson announced plans to buy the biopharmaceutical company. Intra-Cellular shareholders will ...

Johnson & Johnson JNJ4.13%increase; green up pointing triangle agreed to acquire mental-illness drug developer Intra-Cellular Therapies ITCI-0.11%decrease; red down pointing triangle for about $15 ...